Feeley et al v. Bayer Corp. et al
Keli Phillippo, Christine Marie Tartt, Aretha Smith, Jayme Dawn Sala, Stephanie Malone, Lori Gardner, Jeron Balazi, Tami Rodriguez, Vanessa Sue Emery, Kerri Burns, Kelli Payne, Pamela Miller, Regina Feeley, Amanda Amburgey, Brittny Cornett, Amelia Dawn Whennen, Catherine Anderson and Kimberly Gail Trainor |
Bayer Healthcare Pharmaceuticals, Inc., Bayer Corp., Bayer Healthcare LLC and Bayer Essure, Inc. |
3:2018cv02090 |
November 16, 2018 |
US District Court for the Southern District of Illinois |
Nancy J Rosenstengel |
Gilbert C Sison |
Personal Inj. Prod. Liability |
28 U.S.C. § 1332 |
Both |
Docket Report
This docket was last retrieved on September 9, 2019. A more recent docket listing may be available from PACER.
Document Text |
---|
Filing 22 REPLY to Response to Motion re #12 MOTION to Sever filed by Bayer Corp., Bayer Essure, Inc., Bayer Healthcare LLC, Bayer Healthcare Pharmaceuticals, Inc.. (Rankin, W.) |
Filing 21 NOTICE OF MODIFICATION re #20 Response to Motion. Incorrect filing event chosen. Document attached is a Reply Brief. Filer should have used the event "Reply to Response to Motion." Docket text has been modified as follows: REPLY to Response to Motion re #8 MOTION to Remand. No further action is required by the filer in relation to this notification. (kek)THIS TEXT ENTRY IS AN ORDER OF THE COURT. NO FURTHER DOCUMENTATION WILL BE MAILED. |
Filing 20 REPLY to Response to Motion re #8 MOTION to Remand and Memorandum of Law in Support filed by All Plaintiffs. (Callis, Ann) Modified on 1/7/2019 (kek). |
Filing 19 Case reassigned to Magistrate Judge Gilbert C. Sison. Magistrate Judge Stephen C. Williams no longer assigned to the case. (jaj) |
Filing 18 RESPONSE in Opposition re #12 MOTION to Sever filed by All Plaintiffs. (Callis, Ann) |
Filing 17 RESPONSE in Opposition re #9 MOTION to Dismiss for Failure to State a Claim filed by All Plaintiffs. (Attachments: #1 Exhibit Ex. A-MTD Leach v. Bayer Corp.)(Callis, Ann) |
Filing 16 RESPONSE in Opposition re #8 MOTION to Remand and Memorandum of Law in Support filed by Bayer Corp., Bayer Essure, Inc., Bayer Healthcare LLC, Bayer Healthcare Pharmaceuticals, Inc.. (Rankin, W.) |
Filing 15 NOTICE of Appearance by Ann E. Callis on behalf of All Plaintiffs (Callis, Ann) |
Filing 14 NOTICE OF ACTION. See Local Rule 83.1(f). In all cases filed in, removed to, or transferred to this Court, all attorneys, including government attorneys, shall file a written entry of appearance before addressing the court. Attorney Callis does not have a Notice of Appearance on file in this case. (kls3)THIS TEXT ENTRY IS AN ORDER OF THE COURT. NO FURTHER DOCUMENTATION WILL BE MAILED. |
Filing 13 MEMORANDUM in Support re #12 MOTION to Sever filed by Bayer Corp., Bayer Essure, Inc., Bayer Healthcare LLC, Bayer Healthcare Pharmaceuticals, Inc.. (Attachments: #1 Exhibit Exhibit A - 2002 Instructions For Use, #2 Exhibit Exhibit B - 2013 Instructions For Use, #3 Exhibit Exhibit C - Patient Decision Checklist, Appendix B to FDA Final Guidance)(Rankin, W.) |
Filing 12 MOTION to Sever by Bayer Corp., Bayer Essure, Inc., Bayer Healthcare LLC, Bayer Healthcare Pharmaceuticals, Inc.. (Rankin, W.) |
Filing 11 EXHIBIT by Bayer Corp., Bayer Essure, Inc., Bayer Healthcare LLC, Bayer Healthcare Pharmaceuticals, Inc.. Exhibit to #10 Memorandum in Support of Motion Defendants' Request for Judicial Notice. (Attachments: #1 Exhibit Exhibit A - FDA Activities 8-24-2018, #2 Exhibit Exhibit B - Medali v. Bayer HealthCare LLC, No. RG15771555, slip op. (Cal. Super Ct. Feb. 16, 2016), #3 Exhibit Exhibit C - Noris v. Bayer Essure, Inc., No. BC589882, docket & transcript excerpts (Cal. Super. Ct. Apr. 26, 2016), #4 Exhibit Exhibit D - Lance v. Bayer Essure Inc., No. RG16809860 (Cal. Super. Ct. Aug. 2, 2016), #5 Exhibit Exhibit E: - Journey v. Bayer Corp., No. RG16810409 (Cal. Super. Ct. Apr. 12, 2017), #6 Exhibit Exhibit F - Birruete v. Bayer Corp., No. RG16809875 (Cal. Super. Ct. Mar. 28, 2018), #7 Exhibit Exhibit G - FDA, Premarket Approval Order for the Essure System (Nov. 4, 2002), #8 Exhibit Exhibit H: - FDA, Summary of Safety and Effectiveness Data for Essure System (Nov. 4, 2002), #9 Exhibit Exhibit I - FDA, Essure System PMA Supplements, #10 Exhibit Exhibit J - FDA, Regulatory History, #11 Exhibit Exhibit K - Essure Instructions for Use (2002), #12 Exhibit Exhibit L - Essure Instructions for Use (2013), #13 Exhibit Exhibit M - Essure Patient Information Booklet (2015), #14 Exhibit Exhibit N - Essure Patient Information Booklet (2012), #15 Exhibit Exhibit O - Essure Instructions for Use (2008), #16 Exhibit Exhibit P - Essure Patient Information Booklet (2008), #17 Exhibit Exhibit Q - Essure Instructions for Use (2011), #18 Exhibit Exhibit R - Essure Instructions for Use (2016), #19 Exhibit Exhibit S - FDA, Guidance for Industry and Food and Drug Administration Staff: Labeling for Permanent Hysteroscopically-Placed Tubal Implants Intended for Sterilization (Oct. 31, 2016), #20 Exhibit Exhibit T - Citizen Petition to FDA Regarding Essure (Feb. 20, 2015), #21 Exhibit Exhibit U - Gomez v. Bayer Corp., No. MID-L-4930-17 (N.J. Super. Ct. Aug. 31, 2018))(Rankin, W.) |
Filing 10 MEMORANDUM in Support re #9 MOTION to Dismiss for Failure to State a Claim filed by Bayer Corp., Bayer Essure, Inc., Bayer Healthcare LLC, Bayer Healthcare Pharmaceuticals, Inc.. (Rankin, W.) |
Filing 9 MOTION to Dismiss for Failure to State a Claim by Bayer Corp., Bayer Essure, Inc., Bayer Healthcare LLC, Bayer Healthcare Pharmaceuticals, Inc.. Responses due by 1/2/2019 (Rankin, W.) |
Filing 8 MOTION to Remand and Memorandum of Law in Support by All Plaintiffs. Responses due by 12/26/2018 (Attachments: #1 Exhibit Exhibit A Patient Brochure, #2 Exhibit Exhibit B Physician Brochure)(Callis, Ann) |
Filing 7 ORDER GRANTING #6 Motion for Leave to File Excess Pages. Defendants' Motion to Dismiss shall not exceed 26 pages in length. Plaintiffs' Response to that motion shall also not exceed 26 pages in length. Signed by Judge Nancy J. Rosenstengel on 11/20/2018. (bak)THIS TEXT ENTRY IS AN ORDER OF THE COURT. NO FURTHER DOCUMENTATION WILL BE MAILED. |
Filing 6 MOTION for Leave to File Excess Pages to Memorandum of Law in Support of its Motion to Dismiss by Bayer Corp., Bayer Essure, Inc., Bayer Healthcare LLC, Bayer Healthcare Pharmaceuticals, Inc.. (Rankin, W.) |
Filing 5 NOTICE of Appearance by Mary Elizabeth Dyer Kellett on behalf of Bayer Corp., Bayer Essure, Inc., Bayer Healthcare LLC, Bayer Healthcare Pharmaceuticals, Inc. (Dyer Kellett, Mary) |
Filing 4 Notice of Judge Assignment. Judge Nancy J. Rosenstengel and Magistrate Judge Stephen C. Williams assigned. All future documents must bear case number 18-2090-NJR-SCW. If the parties consent to Magistrate Judge assignment, the consent form with instruction is attached for your convenience. (kek) |
Filing 3 Corporate Disclosure Statement by Bayer Corp., Bayer Essure, Inc., Bayer Healthcare LLC, Bayer Healthcare Pharmaceuticals, Inc.. (Rankin, W.) |
Filing 2 NOTICE of Appearance by W. Jason Rankin on behalf of Bayer Corp., Bayer Essure, Inc., Bayer Healthcare LLC, Bayer Healthcare Pharmaceuticals, Inc. (Rankin, W.) |
Filing 1 NOTICE OF REMOVAL from Madison County, case number 2018-L-001395 ( Filing fee $ 400 receipt number 0754-3724504), filed by Bayer Essure, Inc., Bayer Healthcare Pharmaceuticals, Inc., Bayer Healthcare LLC, Bayer Corp.. (Attachments: #1 Exhibit A - State Court File, #2 Exhibit B, #3 Exhibit C, #4 Exhibit D, #5 Civil Cover Sheet Civil Cover Sheet)(Rankin, W.) |
Access additional case information on PACER
Use the links below to access additional information about this case on the US Court's PACER system. A subscription to PACER is required.
Access this case on the Illinois Southern District Court's Electronic Court Filings (ECF) System
- Search for Party Aliases
- Associated Cases
- Attorneys
- Case File Location
- Case Summary
- Docket Report
- History/Documents
- Parties
- Related Transactions
- Check Status
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.